481 results on '"Assi, Tarek"'
Search Results
102. A network meta-analysis of the PD(L)-1 inhibitors in the salvage treatment of urothelial bladder cancer
103. Upfront isolated limb perfusion (ILP) in untreated patients with unresectable non-metastatic primary soft-tissue sarcomas (STS) of the limb: The Gustave Roussy experience.
104. Different inhibitors for the same target in metastatic luminal breast cancer: is there any difference?
105. How Can Eastern/Southern Mediterranean Countries Resolve Quality and Safety Issues in Transfusion Medicine?
106. Toxicities Associated with Docetaxel-Based Regimens in the Adjuvant Treatment of Early-Stage Breast Cancer: A Multicenter Prospective Real-Life Experience
107. The optimal treatment of metastatic hormone-naive prostate cancer: abiraterone acetate or docetaxel?
108. Untreated chronic lymphocytic leukemia in Lebanese patients: an observational study using standard karyotyping and FISH
109. A Two-Front War : Targeting Synchronous Metastatic Pancreatic and Renal Cell Carcinomas with the Combination of Gemcitabine and Sunitinib
110. Advances in urothelial bladder cancer immunotherapy, dawn of a new age of treatment
111. PDL-1/PD1 inhibitors: antibody or antinobody?
112. Markers of arterial stiffness in a sample of Lebanese subjects with Grade I essential hypertension
113. MP166EVALUATION OF CHRONIC KIDNEY DISEASE IN CANCER PATIENTS: IS THERE STILL A ROLE FOR THE COCKROFT-GAULT ESTIMATION
114. Allergic diseases, smoking, and environmental exposure among university students in Lebanon
115. An unexpected response to second line EGFR inhibitor in relapsing leptomeningeal carcinomatosis from lung adenocarcinoma raises questions on differential mechanisms of action of these agents
116. Advances in urothelial bladder cancer immunotherapy, dawn of a new age of treatment
117. Diffuse edema suggestive of cytokine release syndrome in a metastatic lung carcinoma patient treated with pembrolizumab
118. Inflammatory Breast Cancer : A Race against Screening
119. Is minimal residual disease a convincing tool to determine the treatment duration of immune checkpoint inhibitors?
120. Coronary Heart Disease Risk in Patients with Schizophrenia: A Lebanese Cross-Sectional Study
121. Nutrition, oxidative stress and intestinal dysbiosis: Influence of diet on gut microbiota in inflammatory bowel diseases
122. The Forgotten Complication of Recurrent Nephrolithiasis: 'Squamous Cell Carcinoma of the Renal Pelvis'—A Case and Review of the Literature
123. Solitary Laryngeal Metastasis from Transitional Cell Carcinoma of the Kidney: Clinical Case and Review of the Literature
124. Isolated Celiac and Splenic Artery Dissection: A Case Report and Review of the Literature
125. Do we have a clear IDEA for the duration of chemotherapy in stage III colorectal cancer?
126. Personalized treatment of prostate cancer: Better knowledge of the patient, the disease and the medicine
127. Clinical effectiveness and comparative hospital costs of different platelet dose strategies
128. Current applications of therapeutic phlebotomy
129. The role of palliative care in the last month of life in elderly cancer patients
130. Personalized treatment of prostate cancer: better knowledge of the patient, the disease and the medicine
131. Acquired factor inhibitor in a patient with monoclonal gammopathy of undetermined significance responding to rituximab
132. Characteristics of Incident Testicular Cancer in Lebanon - 1990-2015 Single Institutional Experience
133. Dilemma of first line regimens in metastatic pancreatic adenocarcinoma
134. Validation of the EORTC QLQ-INFO 25 questionnaire in Lebanese cancer patients: Is ignorance a Bliss?
135. Geriatric cancer trends in the Middle-East: Findings from Lebanese cancer projections until 2025.
136. Characteristics of Gastric Cancer in Lebanon: a Descriptive Study from a Single Institutional Experience.
137. Allergic diseases, smoking, and environmental exposure among university students in Lebanon.
138. Paraneoplastic syndromes in cancers of unknown primary: An unknown field for oncologists
139. Overview of the role of liquid biopsy in cancer management
140. Treatment of cancer patients in their last month of life: aimless chemotherapy
141. Distribution of Testicular Tumors in Lebanon: A Single Institution Overview
142. Can a decentralized blood system ensure self-sufficiency and blood safety? The Lebanese experience.
143. Viral-induced Hemorrhagic Cystitis After Allogeneic Hematopoietic Stem Cell Transplant.
144. Abridged geriatric assessment is a better predictor of overall survival than the Karnofsky Performance Scale and Physical Performance Test in elderly patients with cancer.
145. A 30 YEAR EXPERIENCE IN THE MANAGEMENT OF ANAL FISTULA.
146. Pruritus Ani : More than a Decade of Personal Experience in Lebanon
147. First Report of a Deletion Encompassing an Entire Exon in the Homogentisate 1,2-Dioxygenase Gene Causing Alkaptonuria
148. Epigallocatechin-3-gallate Reduces Mast Cells Activity TNF-α and NFKB in Colitis by Interrupting an Inflammatory Cascade (MUC2P.827)
149. 25 years’ experience in the management of pilonidal sinus disease
150. Estrogens Control Inflammatory Mediators in Experimental Colitis
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.